CAPTRUST Financial Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,222
Closed -$44K 2279
2022
Q2
$44K Buy
5,222
+1,112
+27% +$15.5K ﹤0.01% 2842
2022
Q1
$94K Buy
4,110
+175
+4% +$4.28K ﹤0.01% 2321
2021
Q4
$109K Buy
3,935
+1,035
+36% +$27.7K ﹤0.01% 2099
2021
Q3
$81K Buy
2,900
+200
+7% +$5.67K ﹤0.01% 2237
2021
Q2
$79K Hold
2,700
﹤0.01% 2206
2021
Q1
$86K Sell
2,700
-835
-24% -$24.5K ﹤0.01% 2062
2020
Q4
$74K Hold
3,535
﹤0.01% 1654
2020
Q3
$56K Hold
3,535
﹤0.01% 1589
2020
Q2
$65K Buy
+3,535
New +$62.3K ﹤0.01% 1518
2019
Q4
Sell
-2,835
Closed -$62K 1085
2019
Q3
$62K Hold
2,835
﹤0.01% 927
2019
Q2
$71K Buy
2,835
+835
+42% +$19.8K ﹤0.01% 866
2019
Q1
$49K Hold
2,000
﹤0.01% 913
2018
Q4
$37K Hold
2,000
﹤0.01% 854
2018
Q3
$51K Hold
2,000
﹤0.01% 766
2018
Q2
$46K Buy
2,000
+200
+11% +$4.14K ﹤0.01% 699
2018
Q1
$27K Sell
1,800
-500
-22% -$9.31K ﹤0.01% 738
2017
Q4
$48K Buy
+2,300
New +$36.5K ﹤0.01% 599

Other funds holding BHC

CAPTRUST Financial Advisors's BHC Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 5,222 shares — an estimated $44K sold.

CAPTRUST Financial Advisors first reported a position in BHC in Q4 2017 and held it in 17 quarters. The position peaked at $109K in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 5,222 Bausch Health shares in Q3 2022, an estimated $44K.
  • CAPTRUST Financial Advisors first reported a position in Bausch Health in Q4 2017 and held it in 17 quarters.
  • CAPTRUST Financial Advisors's Bausch Health position peaked at $109K in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.